Clinical Trial Update: Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for peginterferon alpha-2b in chronic hepatitis B patients with normal ALT and low viremia (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alpha-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia | Phase 1, Phase 2 | Status: UNKNOWN